Lisa Wyman Acquires Shares in PepGen Inc.
Lisa Wyman bought 34,000 shares of PepGen Inc. on June 18, 2026.
Key Points
- Lisa Wyman purchased 34,000 shares of PepGen Inc. on June 18, 2026, with the stock trading at $1.79 per share on Tuesday.
- PepGen Inc. operates in the biotechnology sector with a market cap of approximately $126.6 million and a 52-week range of $1.01 to $7.80.
- Analysts have set a mean price target of $10.25 for PepGen Inc., with a strong buy consensus among eight opinions.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 18, 2026, Lisa Wyman purchased 34,000 shares of PepGen Inc. (NasdaqGS: PEPG). The transaction was not part of a pre-planned trading program. Shares of PepGen traded at $1.79 on Tuesday.
Insider Buying and Selling at PepGen Inc.
Lisa Wyman was among several insiders who bought shares of PepGen on June 18, 2026. Each insider, including Heidi Henson, Laurie Keating, Habib Dable, and Mitchell Finer, acquired 34,000 shares. These purchases were not made under Rule 10b5-1 plans.
Other Institutional Activity in PepGen Inc.
RA Capital Management, L.P. maintained its holdings in PepGen with 20,064,545 shares valued at $35.5 million. Commodore Capital LP increased its stake by 1,075,000 shares, bringing its total to 4,475,000 shares worth approximately $7.92 million, a 31.6% rise. Laurion Capital Management LP also boosted its position by 698,722 shares to hold 2,750,855 shares valued at $4.87 million, marking a 34% increase. Millennium Management LLC made a significant move by adding 1,881,200 shares, bringing its total to 2,079,143 shares valued at roughly $3.68 million, a 950.4% increase.
PepGen Inc. Stock Down 40.6%
PepGen Inc., a biotechnology company based in Boston, Massachusetts, has a market capitalization of about $126.6 million. The stock has seen a 52-week low of $1.01 and a high of $7.80. It has a beta of 1.927, indicating higher volatility compared to the market. The company's forward P/E ratio is not meaningful due to negative earnings per share. Currently, the stock's 50-day moving average is $1.60, and its 200-day moving average is $4.05. PepGen has strong liquidity, with a current ratio of 14.98 and a quick ratio of 14.76.
$PEPG stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 16, 2026, Craig-Hallum initiated coverage of PepGen with a "buy" rating and an $11.00 price target. Wedbush maintained its "buy" rating with a $4.00 target on May 13, 2026. Oppenheimer also initiated a "buy" rating with a $15.00 target on February 25, 2026. The consensus among eight analysts is a "strong buy," with a mean price target of $10.25.
About PepGen Inc.
PepGen Inc. is a clinical-stage biotechnology company focused on developing oligonucleotide therapeutics for severe neuromuscular and neurological diseases. Headquartered in Boston, Massachusetts, the company is led by CEO Dr. James G. McArthur. Founded in 2018, PepGen is working on treatments like PGN-EDODM1, currently in Phase 2 clinical trials for myotonic dystrophy type 1.
Bottom Line
Lisa Wyman's purchase of PepGen shares highlights insider confidence in the company's potential. PepGen operates in the competitive biotechnology sector with promising developments in its treatment pipeline. Investors keep a close watch on insider activities and analyst ratings to gauge future performance. As always, it's important to remember that insider transactions are disclosed after the fact and may not reflect current positions.
Get PepGen Inc. alerts
New 13F filings, insider trades, and analyst moves on $PEPG, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.